Clorazepate Dipotassium Tablet
Product Images NDC 13107-321

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Clorazepate Dipotassium (NDC 13107-321). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurolife Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clorazepate-dipotassium-tab-15-mg100s-jpg.jpg (Clorazepate Dipotassium Tab 15 mg100s Jpg)

Clorazepate-dipotassium-tab-15-mg100s-jpg.jpg (Clorazepate Dipotassium Tab 15 mg100s Jpg)
This is a medication information sheet for Clorazepate Dipotassium Tablets. Each tablet contains 15mg of Clorazepate dipotassium, USP. It should be dispensed in a tightly closed, light-resistant container with child-resistant closure, and stored at room temperature. The medication is distributed by Aurobindo Pharma USA and made in Australia. The recommended dosage for adults should be followed as per the prescribing information. Pharmacists should provide patients with the accompanying medication guide.*
FDA Label Image

Clorazepate-dipotassium-tab-375-mg100s-jpg.jpg (Clorazepate Dipotassium Tab 375 mg100s Jpg)

Clorazepate-dipotassium-tab-375-mg100s-jpg.jpg (Clorazepate Dipotassium Tab 375 mg100s Jpg)
This is a description for Clorazepate Dipotassium tablets with a dose of 375 mg per tablet. The medication should be stored in a tightly closed, light-resistant container at room temperature and protected from moisture. It is recommended to keep this medication out of the reach of children. The accompanying prescribing information should be referred to for instructions on dosage. This medication is distributed by Aurobindo Pharma USA, Inc. and is made in Australia. The NDC number for this medication is 13107-319-01, and it is only available with a prescription from a healthcare professional.*
FDA Label Image

Clorazepate-dipotassium-tab-75-mg100s-jpg.jpg (Clorazepate Dipotassium Tab 75 mg100s Jpg)

Clorazepate-dipotassium-tab-75-mg100s-jpg.jpg (Clorazepate Dipotassium Tab 75 mg100s Jpg)
Clorazepate Dipotassium Tablets, USP is a prescription medication that contains 75mg of Clorazepate dipotassium. It comes in a tightly closed, light-resistant container. This medication must be kept in a secure location and stored at 20°C to 25°C. The medication should be protected from moisture and light. The typical adult dose should be determined by accompanying prescribing information. The medication is distributed by Aurobindo Pharma USA, Inc. and made in Australia. Pharmacist should dispense the medication along with a medication guide to each patient. NDC 13107-320-01. This description is for informational purposes only and not a substitute for medical advice.*
FDA Label Image

Structure.jpg (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.